Nu Skin Enterprises (NUS) Buy Rating and $75 PT Maintained at Pivotal Research
Tweet Send to a Friend
Pivotal Research maintained a Buy rating on Nu Skin Enterprises (NYSE: NUS) with a price target of $75. Analyst Timothy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
